» Articles » PMID: 32283527

Inhibition of CGAS-Mediated Interferon Response Facilitates Transgene Expression

Overview
Journal iScience
Publisher Cell Press
Date 2020 Apr 14
PMID 32283527
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

DNA transfection is often the bottleneck of research and gene therapy practices. To explore the mechanism regulating transgene expression, we investigated the role of the cGAS-STING signaling pathway, which induces type-I interferons in response to DNA. We confirmed that deletion of cGAS enhances transgene expression at the protein level by ~2- to 3-fold. This enhancement is inversely correlated with the expression of interferons and interferon stimulated genes (ISGs), which suppress expression of transfected genes at the mRNA level. Mechanistically, DNA transfection activates the cGAS-STING pathway and induces the expression of the OAS family proteins, leading to the activation of RNaseL and degradation of mRNA derived from transgenes. Administration of chemical inhibitors that block cGAS-mediated signaling cascades improves the expression of transgenes by ~1.5- to 3-fold in multiple cell lines and primary cells, including T cells. These data suggest that targeting the cGAS-STING pathway can improve transgene expression, and this strategy may be applied to gene therapy.

Citing Articles

Induction of translation-suppressive G3BP1 stress granules and interferon-signaling cGAS condensates by transfected plasmid DNA.

Majerciak V, Zheng Z Hlife. 2025; 3(1):21-37.

PMID: 40078969 PMC: 11902918. DOI: 10.1016/j.hlife.2024.11.005.


STING inhibition enables efficient plasmid-based gene expression in primary vascular cells: A simple and cost-effective transfection protocol.

Yuan S, Straub A PLoS One. 2024; 19(7):e0303472.

PMID: 38990864 PMC: 11238992. DOI: 10.1371/journal.pone.0303472.


Revival of Bioengineered Proteins as Carriers for Nucleic Acids.

Scherer D, Burger M, Leroux J Bioconjug Chem. 2024; 35(5):561-566.

PMID: 38621363 PMC: 11099893. DOI: 10.1021/acs.bioconjchem.4c00079.


At the Crossroads of the cGAS-cGAMP-STING Pathway and the DNA Damage Response: Implications for Cancer Progression and Treatment.

Korneenko T, Pestov N, Nevzorov I, Daks A, Trachuk K, Solopova O Pharmaceuticals (Basel). 2023; 16(12).

PMID: 38139802 PMC: 10747911. DOI: 10.3390/ph16121675.


Advances in dendritic cell targeting nano-delivery systems for induction of immune tolerance.

Lin G, Wang J, Yang Y, Zhang Y, Sun T Front Bioeng Biotechnol. 2023; 11:1242126.

PMID: 37877041 PMC: 10593475. DOI: 10.3389/fbioe.2023.1242126.


References
1.
Lai W, Chang C, Farber D . Gene transfection and expression in resting and activated murine CD4 T cell subsets. J Immunol Methods. 2003; 282(1-2):93-102. DOI: 10.1016/j.jim.2003.07.015. View

2.
Clark K, Plater L, Peggie M, Cohen P . Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation. J Biol Chem. 2009; 284(21):14136-46. PMC: 2682862. DOI: 10.1074/jbc.M109.000414. View

3.
Fischer D, Bieber T, Li Y, Elsasser H, Kissel T . A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res. 1999; 16(8):1273-9. DOI: 10.1023/a:1014861900478. View

4.
Bosnjak M, Kamensek U, Sersa G, Stolfa D, Lavrencak J, Cemazar M . Inhibition of the Innate Immune Receptors for Foreign DNA Sensing Improves Transfection Efficiency of Gene Electrotransfer in Melanoma B16F10 Cells. J Membr Biol. 2017; 251(2):179-185. PMC: 6230956. DOI: 10.1007/s00232-017-9948-z. View

5.
Wurm F . Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol. 2004; 22(11):1393-8. DOI: 10.1038/nbt1026. View